Tagrisso Avrupa Birliği - Danca - EMA (European Medicines Agency)

tagrisso

astrazeneca ab - osimertinib mesilate - carcinom, ikke-småcellet lunge - andre antineoplastiske midler, protein kinase hæmmere - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

Lidokain "Mylan" 10 mg/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "mylan" 10 mg/ml injektionsvæske, opløsning

mylan ireland limited - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning - 10 mg/ml

Lidokain "Mylan" 20 mg/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

lidokain "mylan" 20 mg/ml injektionsvæske, opløsning

mylan ireland limited - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning - 20 mg/ml

Lomexin 200 mg vaginalkapsler, bløde Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

lomexin 200 mg vaginalkapsler, bløde

recordati ireland limited - fenticonazolnitrat - vaginalkapsler, bløde - 200 mg

Xylocain 10 mg/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

xylocain 10 mg/ml injektionsvæske, opløsning

aspen pharma trading limited - lidocainhydrochlorid - injektionsvæske, opløsning - 10 mg/ml

Xylocain-adrenalin 10 mg/ml+5 mikrog/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

xylocain-adrenalin 10 mg/ml+5 mikrog/ml injektionsvæske, opløsning

aspen pharma trading limited - adrenalintartrat, lidocainhydrochlorid, vandfrit - injektionsvæske, opløsning - 10 mg/ml+5 mikrog/ml

Xylocaine 20 mg/g gel Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

xylocaine 20 mg/g gel

orifarm a/s - lidocainhydrochlorid - gel - 20 mg/g

Xylocaine 10 mg/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

xylocaine 10 mg/ml injektionsvæske, opløsning

orifarm a/s - lidocainhydrochlorid - injektionsvæske, opløsning - 10 mg/ml

Xylocaine Ukonserveret 10 mg/ml injektionsvæske, opløsning Danimarka - Danca - Lægemiddelstyrelsen (Danish Medicines Agency)

xylocaine ukonserveret 10 mg/ml injektionsvæske, opløsning

orifarm a/s - lidocainhydrochlorid - injektionsvæske, opløsning - 10 mg/ml

NeemAzal T/S (dispensation 2014-2016) Emulsionskoncentrat Danimarka - Danca - SEGES Landbrug & Fødevarer

neemazal t/s (dispensation 2014-2016) emulsionskoncentrat

trifolio-m gmbh - azadirachtin - emulsionskoncentrat - 10 g/l azadirachtin